Follow
Andre Manfred Willasch (MD, PD, PhD)
Andre Manfred Willasch (MD, PD, PhD)
Verified email at kgu.de
Title
Cited by
Cited by
Year
Prognostic value of minimal residual disease quantification before allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia: the ALL-REZ BFM …
P Bader, H Kreyenberg, GHR Henze, C Eckert, M Reising, A Willasch, ...
Journal of Clinical Oncology 27 (3), 377-384, 2009
4202009
How and when should we monitor chimerism after allogeneic stem cell transplantation?
P Bader, D Niethammer, A Willasch, H Kreyenberg, T Klingebiel
Bone marrow transplantation 35 (2), 107-119, 2005
2872005
Ketoacidosis at onset of type 1 diabetes mellitus in children–frequency and clinical presentation
A Neu, A Willasch, S Ehehalt, R Hub, MB Ranke, ...
Pediatric diabetes 4 (2), 77-81, 2003
2302003
Clinical relevance of Wilms tumor 1 gene mutations in childhood acute myeloid leukemia
IHIM Hollink, MM van den Heuvel-Eibrink, M Zimmermann, BV Balgobind, ...
Blood, The Journal of the American Society of Hematology 113 (23), 5951-5960, 2009
1562009
Monitoring of minimal residual disease after allogeneic stem-cell transplantation in relapsed childhood acute lymphoblastic leukemia allows for the identification of impending …
P Bader, H Kreyenberg, A von Stackelberg, C Eckert, ...
Journal of Clinical Oncology 33 (11), 1275-1284, 2015
1422015
Preemptive immunotherapy in childhood acute myeloid leukemia for patients showing evidence of mixed chimerism after allogeneic stem cell transplantation
E Rettinger, AM Willasch, H Kreyenberg, A Borkhardt, W Holter, ...
Blood, The Journal of the American Society of Hematology 118 (20), 5681-5688, 2011
1352011
The cytotoxic potential of interleukin-15-stimulated cytokine-induced killer cells against leukemia cells
E Rettinger, S KuçI, I Naumann, P Becker, H Kreyenberg, M Anzaghe, ...
Cytotherapy 14 (1), 91-103, 2012
1302012
Continuous rise in incidence of childhood Type 1 diabetes in Germany
S Ehehalt, G Blumenstock, AM Willasch, R Hub, MB Ranke, A Neu, ...
Diabetic Medicine 25 (6), 755-757, 2008
1112008
NCI first international workshop on the biology, prevention, and treatment of relapse after allogeneic hematopoietic stem cell transplantation: report from the committee on …
N Kröger, U Bacher, P Bader, S Böttcher, MJ Borowitz, P Dreger, I Khouri, ...
Biology of Blood and Marrow Transplantation 16 (9), 1187-1211, 2010
1002010
Efficient lysis of rhabdomyosarcoma cells by cytokine-induced killer cells: implications for adoptive immunotherapy after allogeneic stem cell transplantation
S Kuçi, E Rettinger, B Voß, G Weber, M Stais, H Kreyenberg, A Willasch, ...
Haematologica 95 (9), 1579, 2010
972010
More precisely defining risk peri-HCT in pediatric ALL: pre-vs post-MRD measures, serial positivity, and risk modeling
P Bader, E Salzmann-Manrique, A Balduzzi, JH Dalle, AE Woolfrey, M Bar, ...
Blood advances 3 (21), 3393-3405, 2019
942019
Rising incidence of type 1 diabetes in Germany: 12-year trend analysis in children 0–14 years of age
A Neu, S Ehehalt, A Willasch, M Kehrer, R Hub, MB Ranke
Diabetes care 24 (4), 785-786, 2001
892001
Epidemiological perspectives on type 1 diabetes in childhood and adolescence in Germany: 20 years of the Baden-Württemberg Diabetes Incidence Registry (DIARY)
S Ehehalt, K Dietz, AM Willasch, A Neu, ...
Diabetes care 33 (2), 338-340, 2010
832010
Standardization of WT1 mRNA quantitation for minimal residual disease monitoring in childhood AML and implications of WT1 gene mutations: a European multicenter study
AM Willasch, B Gruhn, T Coliva, M Kalinova, G Schneider, H Kreyenberg, ...
Leukemia 23 (8), 1472-1479, 2009
732009
Fertility preservation issues in pediatric hematopoietic stem cell transplantation: practical approaches from the consensus of the Pediatric Diseases Working Party of the EBMT …
A Balduzzi, JH Dalle, K Jahnukainen, M von Wolff, G Lucchini, M Ifversen, ...
Bone marrow transplantation 52 (10), 1406-1415, 2017
692017
Prospective validation of a new method of monitoring minimal residual disease in childhood acute myelogenous leukemia
D Steinbach, P Bader, A Willasch, S Bartholomae, KM Debatin, ...
Clinical Cancer Research 21 (6), 1353-1359, 2015
682015
Diabetes incidence in children of different nationalities: an epidemiological approach to the pathogenesis of diabetes
A Neu, A Willasch, S Ehehalt, M Kehrer, R Hub, MB Ranke
Diabetologia 44, B21-B26, 2001
652001
Outcome of relapse after allogeneic HSCT in children with ALL enrolled in the ALL‐SCT 2003/2007 trial
M Kuhlen, AM Willasch, JH Dalle, J Wachowiak, I Yaniv, M Ifversen, ...
British journal of haematology 180 (1), 82-89, 2018
632018
Rapid immune recovery and low TRM in haploidentical stem cell transplantation in children and adolescence using CD3/CD19-depleted stem cells
P Bader, J Soerensen, A Jarisch, E Ponstingl, T Krenn, J Faber, M Dürken, ...
Best practice & research Clinical haematology 24 (3), 331-337, 2011
632011
Varying clinical presentations at onset of type 1 diabetes mellitus in children–epidemiological evidence for different subtypes of the disease?
A Neu, S Ehehalt, A Willasch, M Kehrer, R Hub, MB Ranke
Pediatric diabetes 2 (4), 147-153, 2001
582001
The system can't perform the operation now. Try again later.
Articles 1–20